This webinar will be hosted live and available on-demand

Wednesday, December 13, 2023 
2:30-3:30 PM ET (11:30 AM-12:30 PM PT) 

Microscopic events create macroscopic organs, and maladaptations in these microscopic events can manifest as macroscopic disease. 3D cell culture is a powerful tool for investigating how spatial relationships and environmental conditions dictate cellular function. In this Technique Talk, Benjamin Freedman will discuss how his laboratory uses human induced-pluripotent stem cell-derived organoids, in concert with other techniques, to explore the kidney for the advancement of tissue regeneration, gene therapy, and drug development.

Learning Objectives

  • Organoids as drug development tools for kidney disease
  • Organoid engraftment in mice
  • Limitations of organoids
  • Future directions for organoid research

Benjamin Freedman, PhD

Benjamin Freedman, PhD
Associate Professor
University of Washington
Chief Science Officer
Plurexa


Sponsored by